Corpus ID: 37264094

Chapter 2 History of Cannabis as Medicine : Nineteenth Century Irish Physicians and Correlations of Their Observations to Modern Research

  title={Chapter 2 History of Cannabis as Medicine : Nineteenth Century Irish Physicians and Correlations of Their Observations to Modern Research},
  author={O WilliamBrooke and Shaughnessy},
Cannabis or hemp has been employed medicinally in Ireland since at least the Anglo-Saxon era, more than 1000 years ago. Its use came to the fore, however when William B. O’Shaughnessy, an Irish physician in India, became familiar with the versatility of Indian hemp in the treatment of rheumatic diseases, tetanus, cholera and epilepsy in 1838. His knowledge, acquired through application of the scientific method combining ethnobotanical teachings, animal experimentation and clinical observations… Expand


Cannabis and epilepsy: An ancient treatment returns to the fore
Resumption of research coupled with mass experimentation by families of epilepsy patients has led to intense interest in cannabis-based medicines for its treatment once more, with greatest focus on cannabidiol, but additional investigation of tetrahydrocannabinol, tetrahYDrocannabinolic acid, and other phytocannabinoids. Expand
Cannabis in India: ancient lore and modern medicine
India is a land steeped in faith and mysticism. Ayurveda, combining the Sanskrit words for life and knowledge, is a system of medicine intertwined inextricably with these traits. That a core ofExpand
Hemp for Headache: An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment
The most prominent physicians of the age in the century between 1842 and 1942 preferred cannabis to other preparations in migraine treatment, and it remained part of Western pharmacopoeias for this indication throughout the period. Expand
On the Preparations of the Indian Hemp, or Gunjah (Cannabis Indica), Their Effects on the Animal System in Health, and Their Utility in the Treatment of Tetanus and Other Convulsive Diseases
There was sufficient to show that hemp possesses, in small doses, an extraordinary power of stimulating the digestive organs, exciting the cerebral system, of acting also on the generative apparatus. Expand
Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis‐Based Medicine
No tolerance to the benefit of Sativex on pain or sleep, nor need for dosage increases have been noted in safety extension studies of up to four years, wherein 40–50% of subjects attained good or very good sleep quality, a key source of disability in chronic pain syndromes that may contribute to patients' quality of life. Expand
Cannabis Treatments in Obstetrics and Gynecology: A Historical Review
The author believes that cannabis extracts may represent an efficacious and safe alternative for treatment of a wide range of conditions in women including dysmenorrhea, dysuria, hyperemesis gravidarum, and menopausal symptoms. Expand
Cannabinoids and Epilepsy
These studies suggest that CBD avoids the psychoactive effects of the endocannabinoid system to provide a well-tolerated, promising therapeutic for the treatment of seizures, while whole-plant cannabis can both contribute to and reduce seizures. Expand
Role of Cannabinoids in Pain Management
It is a curious fact that the authors owe a great deal of their insight into pharmacological treatment of pain to the plant world, and the more recent discovery of the body’s own cannabis-like system, the endocannabinoid system (ECS), which modulates pain under physiological conditions. Expand
Sir William Brooke O' Shaughnessy, F. R. S. (1809-1889) Anglo-Indian forensic chemist
  • M. Gorman
  • Sociology, Medicine
  • Notes and Records of the Royal Society of London
  • 1984
The origins of forensic chemistry are to be found in the practice of A forensic medicine in past centuries and every medical student in Great Britain had access to a course in the forensic applications of his field either through a university professor or the extra-mural practitioners of this subject. Expand
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
Migraine, fibromyalgia, IBS and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines. Expand